ImmunityBio Inc. Common Stock vs Sempra Energy — how do they compare? ImmunityBio Inc. Common Stock trades at $10.72 (market cap $10.51B), while Sempra Energy trades at $81.22 (market cap $52.36B). The key difference: Sempra Energy is far larger — about 5× ImmunityBio Inc. Common Stock's market cap, and Sempra Energy pays a 3.28% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Sempra Energy for 9 Days on average.
| IBRX | SRE | |
|---|---|---|
Market Cap | $10.51B | $52.36B |
Volume | 10,445,785 | 3,338,383 |
Sector | Health | Utilities |
52-Week High | $11.55 | $99.75 |
52-Week Low | $1.98 | $76.90 |
Typical Hold Time | 1 Days | 9 Days |
Enterprise Value | $10.97B | $89.00B |
Dividend Yield | — | 3.28% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Sempra is an energy infrastructure company with regulated utility and energy network businesses. Its operations include electric and gas utilities as well as energy infrastructure in North America.
Read more on SRE →